Michio Yagi

A phase 2b, randomized, double‐blind, multicenter, vehicle‐controlled study to assess the efficacy and safety of two crisaborole regimens in Japanese patients aged 2 years and older with mild‐to‐moderate atopic dermatitis

Kayo Fujita, Michio Yagi, Shinichi Moriwaki et al. · The Journal of Dermatology · 2021 · 18 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis

Ryosuke Ono, Michio Yagi, Akinobu Shôji et al. · The Journal of Dermatology · 2019 · 16 citations

Medicine, Dermatology, Pharmacology +15

Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine

Hidenobu Tanihara, Tetsuya Yamamoto, Makoto Aihara et al. · Advances in Therapy · 2023 · 15 citations · Full text

Medicine, Ophthalmology, Pharmacology +13